right-img

Home | UroGen Pharma Ltd. to Post FY2025 Earnings of $2.62 Per Share, Oppenheimer Forecasts (NASDAQ:URGN)

UroGen Pharma Ltd. to Post FY2025 Earnings of $2.62 Per Share, Oppenheimer Forecasts (NASDAQ:URGN)

March 22, 2021
UroGen Pharma Ltd. (NASDAQ:URGN) – Stock analysts at Oppenheimer issued their FY2025 EPS estimates for shares of UroGen Pharma in a note issued to investors on Friday, March 19th. Oppenheimer analyst L. Gershell expects that the company will earn $2.62 per share for the year. UroGen Pharma (NASDAQ:URGN) last announced its quarterly earnings results on […]
Read more at:https://www.americanbankingnews.com/2021/03/22/urogen-pharma-ltd-to-post-fy2025-earnings-of-2-62-per-share-oppenheimer-forecasts-nasdaqurgn.html

Site Created by finaceandbankingnewsnow.com